4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Design Therapeutics, Inc. (DSGN) operates in the Biotechnology industry and is headquartered in Carlsbad, United States with about 54 employees. Its market capitalization is roughly $844 million. In the fiscal year ended 2025-12-31, DSGN reported $0M in revenue and ($70M) in net income.
Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($80M) | ($62M) | ($78M) | ($68M) | — |
| Net Income | ($70M) | ($50M) | ($67M) | ($63M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($20M) | ($18M) | ($19M) | ($22M) | ($20M) |
| Net Income | ($18M) | ($16M) | ($17M) | ($19M) | ($18M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $226M | $252M | $290M | $341M | — |
| Total Liabilities | $14M | $10M | $12M | $14M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DSGN viewer.
About TickerBase · Data methodology & sources